Mr. Matthew Stober is the President and Chief Executive Officer of Istari Oncology. He has more than 30 years of biopharmaceutical industry experience, leading multinational pharmaceutical organizations through significant transformational change, including the development and commercialization of dozens of breakthrough products, and the management of multiple strategic corporate transactions, including major acquisitions, carveouts and divestitures.
Prior to joining Istari, Mr. Stober led global operations as a corporate officer at pharmaceutical and medical technology companies, most recently as President of Operations at Smith and Nephew. Previously, he was a corporate officer and member of the executive committee at Hospira, where he managed 12,000+ global employees and led a turnaround at the company that resulted in a $17B acquisition by Pfizer. Prior to Hospira, he held global leadership positions at Novartis and GSK.
Mr. Stober earned a Bachelor of Science in chemical engineering from Villanova University. He currently serves on the Board of Directors for Istari Oncology and X-Vax Technology, as well as the Technical Advisory Board at Catalent Biologics.